LHC Group, Inc. (LHCG) Stake Lifted by Sawgrass Asset Management LLC

Share on StockTwits

Sawgrass Asset Management LLC lifted its holdings in LHC Group, Inc. (NASDAQ:LHCG) by 13.3% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 24,375 shares of the health services provider’s stock after purchasing an additional 2,860 shares during the quarter. Sawgrass Asset Management LLC’s holdings in LHC Group were worth $2,702,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. BlackRock Inc. lifted its holdings in shares of LHC Group by 2.7% during the fourth quarter. BlackRock Inc. now owns 4,566,337 shares of the health services provider’s stock valued at $428,687,000 after purchasing an additional 121,385 shares during the last quarter. FMR LLC lifted its holdings in shares of LHC Group by 24.9% during the fourth quarter. FMR LLC now owns 1,123,833 shares of the health services provider’s stock valued at $105,506,000 after purchasing an additional 224,124 shares during the last quarter. Norges Bank purchased a new stake in shares of LHC Group during the fourth quarter valued at $51,535,000. Thrivent Financial for Lutherans lifted its holdings in shares of LHC Group by 9.1% during the fourth quarter. Thrivent Financial for Lutherans now owns 530,693 shares of the health services provider’s stock valued at $49,822,000 after purchasing an additional 44,450 shares during the last quarter. Finally, Rothschild & Co. Asset Management US Inc. lifted its holdings in shares of LHC Group by 1.2% during the fourth quarter. Rothschild & Co. Asset Management US Inc. now owns 455,678 shares of the health services provider’s stock valued at $42,779,000 after purchasing an additional 5,333 shares during the last quarter. 94.07% of the stock is owned by institutional investors.

LHC Group stock traded up $1.16 during mid-day trading on Friday, hitting $119.87. The company’s stock had a trading volume of 1,691 shares, compared to its average volume of 250,679. The company has a market cap of $3.69 billion, a P/E ratio of 33.49, a P/E/G ratio of 1.99 and a beta of 0.87. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.21. LHC Group, Inc. has a 52-week low of $73.09 and a 52-week high of $120.69.

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings data on Wednesday, May 8th. The health services provider reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.08. The firm had revenue of $502.59 million during the quarter, compared to the consensus estimate of $511.16 million. LHC Group had a return on equity of 8.43% and a net margin of 3.83%. On average, equities analysts forecast that LHC Group, Inc. will post 4.3 earnings per share for the current fiscal year.

In other LHC Group news, CEO Keith G. Myers sold 75,000 shares of the company’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $108.53, for a total value of $8,139,750.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Donald Dwayne Stelly sold 448 shares of the company’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $120.00, for a total value of $53,760.00. Following the completion of the transaction, the chief operating officer now directly owns 91,252 shares in the company, valued at $10,950,240. The disclosure for this sale can be found here. Over the last three months, insiders sold 118,324 shares of company stock valued at $12,816,300. Company insiders own 5.20% of the company’s stock.

Several brokerages have recently commented on LHCG. Zacks Investment Research downgraded LHC Group from a “hold” rating to a “sell” rating in a report on Thursday, May 2nd. UBS Group set a $133.00 target price on LHC Group and gave the company a “buy” rating in a report on Friday, May 10th. BidaskClub raised LHC Group from a “buy” rating to a “strong-buy” rating in a report on Friday. Barclays upped their target price on LHC Group from $95.00 to $104.00 and gave the company an “equal weight” rating in a report on Thursday, March 21st. Finally, Jefferies Financial Group upped their target price on LHC Group from $125.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, May 9th. Four investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. LHC Group presently has a consensus rating of “Buy” and a consensus price target of $118.50.

ILLEGAL ACTIVITY NOTICE: This report was posted by Macon Daily and is the sole property of of Macon Daily. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://macondaily.com/2019/05/17/lhc-group-inc-lhcg-stake-lifted-by-sawgrass-asset-management-llc.html.

LHC Group Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Recommended Story: Cryptocurrencies

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.